Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Gavin Ling"'
Publikováno v:
Blood. 140:5617-5618
Publikováno v:
Blood. 140:5586-5587
Autor:
Gavin Ling, Edward G. D. Tuddenham, Igor Kurtov, Tatiana Pospelova, Margarita Timofeeva, Nadezhda Zozulya, Marina Kosinova
Publikováno v:
Blood. 138:1040-1040
Background: FVIII replacement therapy is ineffective for severe haemophilia A (HA) patients who develop inhibitors to FVIII. Patients with intractable inhibitors currently require FVIII mimetics and/or bypassing agents to prevent bleeding. PEGylated
Publikováno v:
Blood. 136:9-9
Introduction Emicizumab (a bispecific antibody mimicking Factor VIIIa) has been authorised for use in the United Kingdom National Health Service (NHS) in severe hemophilia A patients with and without inhibitors since August 2019. The Summary of Produ
Autor:
Beverley J. Hunt, Andrew J. Doyle, Gavin Ling, Claire N. Harrison, Donal P. McLornan, Natalia Curto Garcia, Deepti Radia, Karen Breen
Publikováno v:
Blood. 134:4183-4183
Introduction Myeloproliferative neoplasms (MPN) are associated with an increased rate of venous thromboembolism (VTE), which can be a major cause of morbidity and mortality especially in the more indolent diseases of polycythaemia rubra vera (PV) and